Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)

SHE:301258 Revenue

Suzhou Fushilai Pharmaceutical had revenue of 92.86M CNY in the quarter ending March 31, 2026, a decrease of -17.88%. This brings the company's revenue in the last twelve months to 412.51M, down -7.56% year-over-year. In the year 2025, Suzhou Fushilai Pharmaceutical had annual revenue of 432.73M with 0.76% growth.

• Revenue (ttm): 412.51M
• Revenue Growth: -7.56%
• P/S Ratio: 6.55
• Revenue / Employee: 787.24K
• Employees: 524
• Market Cap: 2.70B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	432.73M	3.26M	0.76%
Dec 31, 2024	429.47M	-59.82M	-12.23%
Dec 31, 2023	489.29M	-78.92M	-13.89%
Jan 1, 2023	568.21M	46.52M	8.92%
Jan 1, 2022	521.70M	44.85M	9.40%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 9, 2026

Data Sources Report a data error